Zogenix MDS, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) (NCT04581733) | Zogenix MDS, Inc. | 2022-09-30 |
| A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency (NCT05017818) | Zogenix MDS, Inc. | 2021-07-23 |
| A RETROspective Study of Patients With TK2d (NCT03701568) | Zogenix MDS, Inc. | 2018-11-19 |
Track Zogenix MDS, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.